ReShape Lifesciences RSLS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 0.19 | 3 | -42.15 | -2 | -21.81 | 6 |
| 2024Q1 | 0.18 | 5 | -39.17 | -2 | -23.21 | 8 |
| 2023Q4 | 0.25 | 7 | -34.85 | -2 | -18.37 | 11 |
| 2023Q3 | 0.34 | 3 | -71.97 | -4 | -35.92 | 8 |
| 2023Q2 | 1.48 | 7 | -48.19 | -3 | -24.77 | 12 |
| 2023Q1 | 2.57 | 8 | -46.62 | -3 | -19.36 | 16 |
| 2022Q4 | 6.74 | 4 | -133.87 | -16 | -83.18 | 11 |
| 2022Q3 | 15.02 | 21 | -45.18 | -12 | -34.22 | 28 |
| 2022Q2 | 28.84 | 32 | -27.26 | -10 | -21.70 | 42 |
| 2022Q1 | 59.00 | 39 | -19.40 | -8 | -16.18 | 47 |
| 2021Q4 | 82.00 | 46 | -56.60 | -35 | -48.92 | 54 |
| 2021Q3 | 144.00 | 79 | -25.77 | -18 | -16.80 | 91 |
| 2021Q2 | 250.00 | 58 | -11.02 | -4 | -5.00 | 120 |
| 2021Q1 | 13 | -35.84 | -5 | -13.34 | 36 | |
| 2020Q4 | 14 | -54.07 | -9 | -23.18 | 37 | |
| 2020Q3 | 17 | -28.58 | -5 | -14.05 | 37 | |
| 2020Q2 | 19 | -4 | 37 | |||
| 2020Q1 | -4 | |||||
| 2019Q4 | -25 | |||||
| 2019Q3 | -29 |